Lumida
/HCA
⌘K
HCA Healthcare Inc

HCA Healthcare Inc

HCA
$371.18USD-3.77%-14.56 today

MARKET CAP

82.3B

P/E (TTM)

12.4x

FWD P/E

11.6x

DAY RANGE

$371 – $386

52W RANGE

$330
$557

AI Summary

Stalk
StalkMedium

HCA is in a Stage 2 – Advancing (Corrective Reset) within a long-term uptrend. A Momentum Breakout in early July confirms new demand overwhelming prior supply, supporting a Bullish medium-term bias and invalidating prior bearish posture. However, short-term execution conditions are Neutral as price consolidates around EMAs. We will Stalk for a pullback into the broken resistance zone (~386–390 area) and look for acceptance above EMAs before committing.

  • Q1 revenue up 4.3% YoY to $15.6B, led by state supplemental programs
  • Operating cash flow increased 22% YoY to $2B, highlighting efficiency
  • Leverage elevated, exposing HCA to higher interest costs as rates rise
Full analysis →
Insider Trades99 trades
DateSideTickerInsiderRoleSharesPriceMkt Cap52W High52W LowValue% ChgRuleAI View
May 7, 2026SellHCAMike A MarksEVP and CFO6,672$429.02$82.3B-33.30%+12.48%$2.9M+0.00%Stalk
Feb 13, 2026SellHCAMichael R McaleveyEVP & Chief Legal & Admin Off.10,000$387.28$82.3B-33.30%+12.48%$3.9M+0.00%Stalk
Feb 10, 2026SellHCAErica RossittoSVP & Chief Nurse Executive418$502.05$82.3B-33.30%+12.48%$209.9K-3.86%Stalk
Feb 10, 2026SellHCAMike A MarksEVP and CFO1,690$502.05$82.3B-33.30%+12.48%$848.5K-33.63%Stalk
Feb 10, 2026SellHCAMichael R McaleveyEVP & Chief Legal & Admin Off.3,006$502.05$82.3B-33.30%+12.48%$1.5M-25.35%Stalk
Feb 10, 2026SellHCAMichael S. CuffeEVP and Chief Clinical Officer3,501$502.05$82.3B-33.30%+12.48%$1.8M-9.84%Stalk
Feb 10, 2026SellHCAChristopher F. WyattSVP & Controller5,034$504.39$82.3B-33.30%+12.48%$2.5M-5.15%Stalk
Feb 10, 2026SellHCAJon M FosterEVP and COO5,888$502.05$82.3B-33.30%+12.48%$3.0M-20.34%Stalk